Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cassava Sciences Inc (SAVA)  
$21.72 0.09 (0.39%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 40,010,000
Market Cap: 868.82(M)
Last Volume: 1,008,943 Avg Vol: 1,006,179
52 Week Range: $12.64 - $30.11
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 48,477 278,477
Total Buy Value $0 $0 $831,428 $6,164,449
Total People Bought 0 0 2 4
Total Buy Transactions 0 0 3 9
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 504
  Page 4 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Roddy Peter S chief Fianancial Officer   •       –      –    2014-07-14 4 D $5.09 $779,025 D/D (153,050) 103,093     -
   Roddy Peter S chief Fianancial Officer   •       –      –    2014-07-14 4 OE $4.54 $779,023 D/D 171,591 256,143     -
   Barbier Remi CEO, Chairman of the Board   •       •       •   2014-07-14 4 D $5.09 $1,949,373 D/D (382,981) 4,369,731     -
   Barbier Remi CEO, Chairman of the Board   •       •       •   2014-07-14 4 OE $4.54 $1,947,574 D/D 428,981 4,752,359     -
   Schoenhard Grant Chief Scientific Officer   •       –      –    2014-07-11 4 D $4.98 $584,269 D/D (117,323) 78,551     -
   Schoenhard Grant Chief Scientific Officer   •       –      –    2014-07-11 4 OE $4.54 $584,266 D/D 128,693 195,874     -
   Friedmann Nadav Chief Operating Officer   •       •      –    2014-07-01 4 D $5.76 $614,419 D/D (106,670) 364,893     -
   Friedmann Nadav Chief Operating Officer   •       •      –    2014-07-01 4 OE $4.54 $614,416 D/D 135,334 471,563     -
   Gussin Robert Z Director   –       •      –    2014-05-27 4 D $4.93 $192,610 D/D (39,069) 27,360     -
   Gussin Robert Z Director   –       •      –    2014-05-27 4 OE $4.49 $192,608 D/D 42,897 66,429     -
   Friedmann Nadav Chief Operating Officer   •       •      –    2014-04-09 4 D $5.65 $554,124 D/D (98,075) 336,229     -
   Friedmann Nadav Chief Operating Officer   •       •      –    2014-04-09 4 OE $4.54 $554,125 D/D 122,054 434,304     -
   Robertson Sanford Director   –       •      –    2014-03-21 4 OE $4.49 $313,319 D/D 68,635 438,362     -
   O Donnell Michael J Director   –       •      –    2014-03-21 4 D $5.53 $192,610 D/D (34,830) 32,118     -
   O Donnell Michael J Director   –       •      –    2014-03-21 4 OE $4.49 $192,608 D/D 42,897 66,948     -
   Barbier Remi CEO, Chairman of the Board   •       •       •   2013-12-12 4 OE $3.65 $144,675 I/I 39,637 2,153,762     -
   Robertson Sanford Director   –       •      –    2013-11-06 4 B $3.76 $119,711 D/D 31,838 369,727 2.39     -
   Robertson Sanford Director   –       •      –    2013-11-04 4 B $3.69 $67,018 D/D 18,162 337,889 2.39     -
   Gussin Robert Z Director   –       •      –    2013-05-08 4 D $5.41 $476,080 D/D (88,000) 23,532     -
   Gussin Robert Z Director   –       •      –    2013-05-08 4 OE $4.10 $476,070 D/D 111,532 56,042     -
   O Donnell Michael J Director   –       •      –    2013-05-07 4 D $5.36 $176,365 D/D (32,904) 24,051     -
   O Donnell Michael J Director   –       •      –    2013-05-07 4 OE $4.10 $175,878 D/D 42,897 56,995     -
   Roddy Peter S Cheif Fianancial Officer   •       –      –    2013-05-01 4 A $1.92 $5,000 D/D 2,604 84,552     -
   Robertson Sanford Director   –       •      –    2013-05-01 4 OE $4.10 $175,878 D/D 42,897 319,727     -
   Schoenhard Grant Chief Scientific Officer   •       –      –    2013-05-01 4 A $1.92 $1,248 D/D 650 67,181     -
  504 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us